Single-lung Transplant in a Patient with Mycobacterium avium Pulmonary Disease Successfully Treated with Amikacin Liposome Inhalation Suspension
Authors:
Open Access
- 1 April 2025
- journal article
- research article
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 64 (7) , 1093-1096
Abstract
A 55-year-old man presented to our hospital with idiopathic pulmonary fibrosis (IPF). He was registered with the Japan Organ Transplant Network the following year due to disease progression. Treatment with clarithromycin, ethambutol, and rifampicin for complications of Mycobacterium avium pulmonary disease was initiated, but sputum conversion could not be achieved. The administration of an amikacin liposome inhalation suspension (ALIS) resulted in sputum conversion, and single-lung transplantation was performed. ALIS therapy was continued after lung transplantation, and no M. avium disease was observed for 15 months. ALIS may cause M. avium pulmonary disease with additional indications for lung transplantation.Keywords
This publication has 15 references indexed in Scilit:
- Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung TransplantationThe Journal of Heart and Lung Transplantation, 2021
- Genome-wide association study in patients with pulmonaryMycobacterium aviumcomplex diseaseEuropean Respiratory Journal, 2021
- Immunosuppressive strategies in lung transplantationAnnals of Translational Medicine, 2020
- Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized StudyAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Nontuberculous mycobacterial and Aspergillus infections among cadaveric lung transplant recipients in JapanRespiratory Investigation, 2018
- Clinical characteristics of Japanese candidates for lung transplant for interstitial lung disease and risk factors for early death while on the waiting listRespiratory Investigation, 2017
- Nontuberculous Mycobacterial Disease Is Not a Contraindication to Lung Transplantation in Patients With Cystic Fibrosis: A Retrospective Analysis in a Danish Patient PopulationTransplantation Proceedings, 2013
- Non-tuberculous mycobacterium infection after lung transplantation is associated with increased mortalityThe Journal of Heart and Lung Transplantation, 2011
- Effects of Rifampin on Tacrolimus Pharmacokinetics in Healthy VolunteersThe Journal of Clinical Pharmacology, 1999
- Interactions Between Tacrolimus and Antimicrobial AgentsClinical Infectious Diseases, 1997